212 related articles for article (PubMed ID: 22287548)
1. Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway.
Chen W; Ma T; Shen XN; Xia XF; Xu GD; Bai XL; Liang TB
Cancer Res; 2012 Mar; 72(6):1363-72. PubMed ID: 22287548
[TBL] [Abstract][Full Text] [Related]
2. Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis.
Varney ML; Olsen KJ; Mosley RL; Bucana CD; Talmadge JE; Singh RK
In Vivo; 2002; 16(6):471-7. PubMed ID: 12494891
[TBL] [Abstract][Full Text] [Related]
3. The TSC-mTOR signaling pathway regulates the innate inflammatory response.
Weichhart T; Costantino G; Poglitsch M; Rosner M; Zeyda M; Stuhlmeier KM; Kolbe T; Stulnig TM; Hörl WH; Hengstschläger M; Müller M; Säemann MD
Immunity; 2008 Oct; 29(4):565-77. PubMed ID: 18848473
[TBL] [Abstract][Full Text] [Related]
4. Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma.
Zhao X; Li J; Zhuo J; Cai L
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):417-21. PubMed ID: 21093415
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation.
Sun T; Yang Y; Luo X; Cheng Y; Zhang M; Wang K; Ge C
Oncol Res; 2014; 21(5):227-35. PubMed ID: 24854099
[TBL] [Abstract][Full Text] [Related]
7. Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.
Ma A; Wang L; Gao Y; Chang Z; Peng H; Zeng N; Gui YS; Tian X; Li X; Cai B; Zhang H; Xu KF
Hum Mol Genet; 2014 Feb; 23(3):693-705. PubMed ID: 24129405
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells.
Aleffi S; Navari N; Delogu W; Galastri S; Novo E; Rombouts K; Pinzani M; Parola M; Marra F
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G210-9. PubMed ID: 21252047
[TBL] [Abstract][Full Text] [Related]
9. Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells.
Benhamron S; Tirosh B
Eur J Immunol; 2011 Aug; 41(8):2390-6. PubMed ID: 21674478
[TBL] [Abstract][Full Text] [Related]
10. Knockout of HIF-1α in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses.
Werno C; Menrad H; Weigert A; Dehne N; Goerdt S; Schledzewski K; Kzhyshkowska J; Brüne B
Carcinogenesis; 2010 Oct; 31(10):1863-72. PubMed ID: 20427344
[TBL] [Abstract][Full Text] [Related]
11. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.
Lee DF; Kuo HP; Chen CT; Hsu JM; Chou CK; Wei Y; Sun HL; Li LY; Ping B; Huang WC; He X; Hung JY; Lai CC; Ding Q; Su JL; Yang JY; Sahin AA; Hortobagyi GN; Tsai FJ; Tsai CH; Hung MC
Cell; 2007 Aug; 130(3):440-55. PubMed ID: 17693255
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
Kaper F; Dornhoefer N; Giaccia AJ
Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
[TBL] [Abstract][Full Text] [Related]
13. Role of tumor-associated macrophages in renal cell carcinoma.
Ikemoto S; Yoshida N; Narita K; Wada S; Kishimoto T; Sugimura K; Nakatani T
Oncol Rep; 2003; 10(6):1843-9. PubMed ID: 14534706
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis.
Zha X; Wang F; Wang Y; He S; Jing Y; Wu X; Zhang H
Cancer Res; 2011 Jan; 71(1):13-8. PubMed ID: 21199794
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
[TBL] [Abstract][Full Text] [Related]
16. Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors.
Jin H; Su J; Garmy-Susini B; Kleeman J; Varner J
Cancer Res; 2006 Feb; 66(4):2146-52. PubMed ID: 16489015
[TBL] [Abstract][Full Text] [Related]
17. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.
Kenerson HL; Aicher LD; True LD; Yeung RS
Cancer Res; 2002 Oct; 62(20):5645-50. PubMed ID: 12384518
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis.
Kimura YN; Watari K; Fotovati A; Hosoi F; Yasumoto K; Izumi H; Kohno K; Umezawa K; Iguchi H; Shirouzu K; Takamori S; Kuwano M; Ono M
Cancer Sci; 2007 Dec; 98(12):2009-18. PubMed ID: 17924976
[TBL] [Abstract][Full Text] [Related]
20. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
Fujiwara Y; Komohara Y; Kudo R; Tsurushima K; Ohnishi K; Ikeda T; Takeya M
Oncol Rep; 2011 Dec; 26(6):1533-7. PubMed ID: 21922144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
